Explore the impact of drug discovery automation in 2026, addressing complexity and improving decision-making across ...

Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. The lab automation market is expected to surpass $8.36 billion globally in 2025 and reach ...

Opentrons, a leader in lab automation, announces the launch of its Opentrons Flex robot, a new generation of affordable and easy-to-program liquid-handling lab robots designed to level the playing ...

Nvidia expands BioNeMo for AI drug discovery with new models, tools, and lab partnerships to automate experiments and speed research—read the details now.

South San Francisco is poised to become an even hotter address for biotech and chip companies. Nvidia and Eli Lilly said ...

The DMTA cycle depends on clear data flow, yet most labs still work across disconnected systems. Sean McGee, Director of ...

Every stage of biopharma drug development depends on what happens in the laboratory. Consequently, any one of these stages—which include target identification, lead optimization, candidate screening, ...

Presentations in this conference track covered the latest technological advances and methods in microfluidics devices. In the keynote address “Commercialization and Entrepreneurial Lessons from ...

Dublin, Dec. 05, 2025 (GLOBE NEWSWIRE) -- The "Laboratory Automation Market - Forecasts from 2025 to 2030" report has been added to ResearchAndMarkets.com's offering. The Laboratory Automation Market ...

How has technology changed the way we conduct research? Lab automation takes many different forms with the purpose of streamlining several aspects of experiments, data collection and data analysis.

Dr. April Schrank-Hacker looks at the benefits of automation in the laboratory to help generate trustworthiness in research. Many times, manual processes used in protocols lead to variability that can ...

Forbes contributors publish independent expert analyses and insights. Gary Drenik is a writer covering AI, analytics and innovation. No topic has been discussed more than Covid-19 in the past two ...